178 related articles for article (PubMed ID: 37238632)
1. Histological Analysis of a Mouse Model of the 22q11.2 Microdeletion Syndrome.
Tabata H; Mori D; Matsuki T; Yoshizaki K; Asai M; Nakayama A; Ozaki N; Nagata KI
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238632
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of a novel mouse model of the 22q11.2 deletion syndrome: a model with the most common 3.0-Mb deletion at the human 22q11.2 locus.
Saito R; Koebis M; Nagai T; Shimizu K; Liao J; Wulaer B; Sugaya Y; Nagahama K; Uesaka N; Kushima I; Mori D; Maruyama K; Nakao K; Kurihara H; Yamada K; Kano M; Fukada Y; Ozaki N; Aiba A
Transl Psychiatry; 2020 Feb; 10(1):35. PubMed ID: 32066675
[TBL] [Abstract][Full Text] [Related]
3. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.
Butcher NJ; Kiehl TR; Hazrati LN; Chow EW; Rogaeva E; Lang AE; Bassett AS
JAMA Neurol; 2013 Nov; 70(11):1359-66. PubMed ID: 24018986
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
Butcher NJ; Marras C; Pondal M; Rusjan P; Boot E; Christopher L; Repetto GM; Fritsch R; Chow EWC; Masellis M; Strafella AP; Lang AE; Bassett AS
Brain; 2017 May; 140(5):1371-1383. PubMed ID: 28369257
[TBL] [Abstract][Full Text] [Related]
5. [22q11.2DS Syndrome as a Genetic Subtype of Schizophrenia].
Huertas-Rodríguez CK; Payán-Gómez C; Forero-Castro RM
Rev Colomb Psiquiatr; 2015; 44(1):50-60. PubMed ID: 26578219
[TBL] [Abstract][Full Text] [Related]
6. Two novel mouse models mimicking minor deletions in 22q11.2 deletion syndrome revealed the contribution of each deleted region to psychiatric disorders.
Saito R; Miyoshi C; Koebis M; Kushima I; Nakao K; Mori D; Ozaki N; Funato H; Yanagisawa M; Aiba A
Mol Brain; 2021 Apr; 14(1):68. PubMed ID: 33845872
[TBL] [Abstract][Full Text] [Related]
7. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
8. Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome.
Zafarullah M; Angkustsiri K; Quach A; Yeo S; Durbin-Johnson BP; Bowling H; Tassone F
Metabolomics; 2024 Feb; 20(2):31. PubMed ID: 38418685
[TBL] [Abstract][Full Text] [Related]
9. Neuroanatomical underpinnings of autism symptomatology in carriers and non-carriers of the 22q11.2 microdeletion.
Gudbrandsen M; Bletsch A; Mann C; Daly E; Murphy CM; Stoencheva V; Blackmore CE; Rogdaki M; Kushan L; Bearden CE; Murphy DGM; Craig MC; Ecker C
Mol Autism; 2020 Jun; 11(1):46. PubMed ID: 32513259
[TBL] [Abstract][Full Text] [Related]
10. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.
Van L; Boot E; Bassett AS
Curr Opin Psychiatry; 2017 May; 30(3):191-196. PubMed ID: 28230630
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of fatigue in adults with a 22q11.2 deletion syndrome.
Vergaelen E; Claes S; Kempke S; Swillen A
Am J Med Genet A; 2017 Apr; 173(4):858-867. PubMed ID: 28190295
[TBL] [Abstract][Full Text] [Related]
12. Sleep in 22q11.2 Deletion Syndrome: Current Findings, Challenges, and Future Directions.
O'Hora KP; Schleifer CH; Bearden CE
Curr Psychiatry Rep; 2023 Oct; 25(10):479-491. PubMed ID: 37721640
[TBL] [Abstract][Full Text] [Related]
13. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
Prasad SE; Howley S; Murphy KC
Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
[TBL] [Abstract][Full Text] [Related]
14. Cognitive behavioral therapy in 22q11.2 microdeletion with psychotic symptoms: What do we learn from schizophrenia?
Demily C; Franck N
Eur J Med Genet; 2016 Nov; 59(11):596-603. PubMed ID: 27639442
[TBL] [Abstract][Full Text] [Related]
15. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
[TBL] [Abstract][Full Text] [Related]
16. Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study.
Gothelf D; Penniman L; Gu E; Eliez S; Reiss AL
Schizophr Res; 2007 Nov; 96(1-3):72-81. PubMed ID: 17804201
[TBL] [Abstract][Full Text] [Related]
17. Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.
Didriksen M; Fejgin K; Nilsson SR; Birknow MR; Grayton HM; Larsen PH; Lauridsen JB; Nielsen V; Celada P; Santana N; Kallunki P; Christensen KV; Werge TM; Stensbøl TB; Egebjerg J; Gastambide F; Artigas F; Bastlund JF; Nielsen J
J Psychiatry Neurosci; 2017 Jan; 42(1):48-58. PubMed ID: 27391101
[TBL] [Abstract][Full Text] [Related]
18. Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis.
Rogdaki M; Gudbrandsen M; McCutcheon RA; Blackmore CE; Brugger S; Ecker C; Craig MC; Daly E; Murphy DGM; Howes O
Mol Psychiatry; 2020 Aug; 25(8):1704-1717. PubMed ID: 31925327
[TBL] [Abstract][Full Text] [Related]
19. Visual processing deficits in 22q11.2 Deletion Syndrome.
Biria M; Tomescu MI; Custo A; Cantonas LM; Song KW; Schneider M; Murray MM; Eliez S; Michel CM; Rihs TA
Neuroimage Clin; 2018; 17():976-986. PubMed ID: 29527499
[TBL] [Abstract][Full Text] [Related]
20. Craniofacial dysmorphology in 22q11.2 deletion syndrome by 3D laser surface imaging and geometric morphometrics: illuminating the developmental relationship to risk for psychosis.
Prasad S; Katina S; Hennessy RJ; Murphy KC; Bowman AW; Waddington JL
Am J Med Genet A; 2015 Mar; 167A(3):529-36. PubMed ID: 25691406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
